Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107562164 | 10756216 | 4 | F | 20160819 | 20150202 | 20160824 | PER | US-PFIZER INC-2015043841 | PFIZER | 49.00 | YR | F | Y | 0.00000 | 20160824 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107562164 | 10756216 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 200 MG, 3X/DAY | 21446 | 200 | MG | CAPSULE, HARD | TID | ||||||
| 107562164 | 10756216 | 2 | C | ACCOLATE | ZAFIRLUKAST | 1 | Oral | 20 MG, 2X/DAY | 0 | 20 | MG | TABLET | BID | ||||||
| 107562164 | 10756216 | 3 | C | BACLOFEN. | BACLOFEN | 1 | Oral | 20 MG, 3X/DAY | 0 | 20 | MG | TABLET | TID | ||||||
| 107562164 | 10756216 | 4 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 2 MG, 1X/DAY | 0 | 2 | MG | TABLET | QD | ||||||
| 107562164 | 10756216 | 5 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 5 MG, 1X/DAY | 0 | 5 | MG | TABLET | QD | ||||||
| 107562164 | 10756216 | 6 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | UNK | 0 | |||||||||||
| 107562164 | 10756216 | 7 | C | AMBIEN CR | ZOLPIDEM TARTRATE | 1 | Oral | 12.5 MG, 1X/DAY ((AT BEDTIME)) | 0 | 12.5 | MG | TABLET | QD | ||||||
| 107562164 | 10756216 | 8 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | Oral | 30 MG, 1X/DAY (AT BEDTIME) | 0 | 30 | MG | TABLET | QD | ||||||
| 107562164 | 10756216 | 9 | C | LASIX | FUROSEMIDE | 1 | Oral | 80 MG, 1X/DAY | 0 | 80 | MG | TABLET | QD | ||||||
| 107562164 | 10756216 | 10 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | UNK | 0 | TABLET | ||||||||||
| 107562164 | 10756216 | 11 | C | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, 2X/DAY | 0 | 75 | MG | TABLET | BID | ||||||
| 107562164 | 10756216 | 12 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 10 MG, 1X/DAY (AT BEDTIME) | 0 | 10 | MG | TABLET | QD | ||||||
| 107562164 | 10756216 | 13 | C | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK | 0 | |||||||||||
| 107562164 | 10756216 | 14 | C | HYDROCODONE | HYDROCODONE | 1 | UNK | 0 | |||||||||||
| 107562164 | 10756216 | 15 | C | XANAX | ALPRAZOLAM | 1 | Oral | 1 MG, 1X/DAY | 0 | 1 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
| 107562164 | 10756216 | 16 | C | CLOTRIMAZOLE. | CLOTRIMAZOLE | 1 | Topical | UNK, 2X/DAY (1% 1 APP APPLIED TOPICALLY) | 0 | CREAM | BID | ||||||||
| 107562164 | 10756216 | 17 | C | ALBUTEROL W/IPRATROPIUM | ALBUTEROLIPRATROPIUM | 1 | UNK UNK, AS NEEDED (IPRATROPIUM 0.5MG, SALBUTAMOL 2.5 MG/3 ML 3 ML INHALED ) | 0 | |||||||||||
| 107562164 | 10756216 | 18 | C | ALBUTEROL. | ALBUTEROL | 1 | UNK, AS NEEDED (CFC FREE 90 MCG/INH 2 PUFF(S) INHALED) | 0 | |||||||||||
| 107562164 | 10756216 | 19 | C | ADVIL | IBUPROFEN | 1 | Oral | 400 MG, EVERY 4 HRS | 0 | 400 | MG | TABLET | |||||||
| 107562164 | 10756216 | 20 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Oral | 400 MG, 1X/DAY | 0 | 400 | MG | TABLET | QD | ||||||
| 107562164 | 10756216 | 21 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK UNK, 2X/DAY (FLUTICASONE PROPIONATE 250 MCG, SALMETEROL XINAFOATE 50 MCG 1 PUFF (S) INHALED) | 0 | BID | ||||||||||
| 107562164 | 10756216 | 22 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | UNK, 4X/DAY (HYDROCODONE BITARTRATE 10 MG + PARACETAMOL 325 MG) | 0 | TABLET | QID | ||||||||
| 107562164 | 10756216 | 23 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107562164 | 10756216 | 1 | Fibromyalgia |
| 107562164 | 10756216 | 7 | Insomnia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107562164 | 10756216 | Insomnia | |
| 107562164 | 10756216 | Stress |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107562164 | 10756216 | 2 | 1998 | 0 |